Published in Am J Respir Crit Care Med on April 14, 2011
Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med (2012) 2.03
Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax (2013) 1.58
Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis (2013) 1.34
Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2014) 1.19
Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. Ann Am Thorac Soc (2014) 0.97
Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med (2012) 0.94
Cystic fibrosis therapeutics: the road ahead. Chest (2013) 0.91
Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients. Biochem Biophys Res Commun (2012) 0.90
Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax (2013) 0.87
Increased expression of senescence markers in cystic fibrosis airways. Am J Physiol Lung Cell Mol Physiol (2013) 0.83
Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease. BMC Pulm Med (2014) 0.82
Early pulmonary disease manifestations in cystic fibrosis mice. J Cyst Fibros (2016) 0.81
Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients--a cross-sectional study. PLoS One (2013) 0.81
Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients. BMC Pulm Med (2015) 0.81
Influenza vaccination among household contacts of children with cystic fibrosis and healthy children. Paediatr Child Health (2013) 0.81
Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. Eur Respir J (2013) 0.79
Azithromycin use in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2015) 0.78
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung. Mediators Inflamm (2015) 0.78
Cystic Fibrosis: Microbiology and Host Response. Pediatr Clin North Am (2016) 0.78
Mycobacterium abscessus morphotype comparison in a murine model. PLoS One (2015) 0.78
Vaccine strategies against cystic fibrosis pathogens. Hum Vaccin Immunother (2016) 0.77
Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential. Biomed Res Int (2015) 0.76
Pseudomonas aeruginosa Airway Infection Recruits and Modulates Neutrophilic Myeloid-Derived Suppressor Cells. Front Cell Infect Microbiol (2016) 0.75
Infant lung function tests as endpoints in the ISIS multicenter clinical trial in cystic fibrosis. J Cyst Fibros (2015) 0.75
Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening. Pediatr Pulmonol (2016) 0.75
Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts. ERJ Open Res (2016) 0.75
Novel end points for clinical trials in young children with cystic fibrosis. Expert Rev Respir Med (2013) 0.75
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium. Front Immunol (2016) 0.75
Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients. Virulence (2016) 0.75
Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis. PLoS One (2016) 0.75
Background and Epidemiology. Pediatr Clin North Am (2016) 0.75
Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa. Med Microbiol Immunol (2016) 0.75
Elevated IgG4 serum levels in patients with cystic fibrosis. PLoS One (2017) 0.75
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J (2012) 7.18
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr (2008) 5.19
An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med (2007) 4.10
An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res (2004) 3.96
Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J (2013) 3.34
Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet (2011) 3.03
PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis. Am J Respir Crit Care Med (2015) 2.70
Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax (2011) 2.58
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44
Lateral wedge insoles for medial knee osteoarthritis: 12 month randomised controlled trial. BMJ (2011) 2.43
Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol (2008) 2.40
Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr (2009) 2.31
Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med (2013) 2.28
Vitamin D deficiency at 16 to 20 weeks' gestation is associated with impaired lung function and asthma at 6 years of age. Ann Am Thorac Soc (2014) 2.14
Transcript-specific, single-nucleotide polymorphism discovery and linkage analysis in hexaploid bread wheat (Triticum aestivum L.). Plant Biotechnol J (2011) 2.13
The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol (2002) 2.07
Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol (2009) 1.99
Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol (2005) 1.90
Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med (2009) 1.87
Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2008) 1.79
Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol (2008) 1.77
Definition of cutoff values for the hypoxia test used for preflight testing in young children with neonatal chronic lung disease. Chest (2007) 1.64
Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth Analg (2010) 1.62
Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med (2014) 1.60
The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol (2004) 1.60
Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet (2011) 1.60
Effects of adopting the new global lung function initiative 2012 reference equations on the interpretation of spirometry. Respiration (2013) 1.55
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics (2007) 1.53
Inhaled steroids - too much of a good thing? Med J Aust (2002) 1.53
The all-age spirometry reference ranges reflect contemporary Australasian spirometry. Respirology (2011) 1.52
Nitrous oxide and serious morbidity and mortality in the POISE trial. Anesth Analg (2013) 1.50
Development of a SNP genotyping panel for genetic monitoring of the laboratory mouse. Genomics (2004) 1.49
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol (2013) 1.47
Paralysis and a perihilar protuberance: an unusual presentation of sarcoidosis in a child. Pediatr Pulmonol (2009) 1.44
Cost-effectiveness of carrier screening for cystic fibrosis in Australia. J Cyst Fibros (2012) 1.42
Sweat testing for cystic fibrosis: standards of performance in Australasia. Ann Clin Biochem (2009) 1.41
Spontaneous chylothorax in a 2-year-old child. Med J Aust (2009) 1.39
Extending the limits of extracorporeal membrane oxygenation: lung rest for a child with non-specific interstitial pneumonia. Intensive Care Med (2005) 1.38
Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax (2006) 1.37
Age- and height-based prediction bias in spirometry reference equations. Eur Respir J (2011) 1.32
Chylothorax: diagnosis and management in children. Paediatr Respir Rev (2009) 1.32
Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med (2008) 1.31
Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative. Am J Respir Crit Care Med (2009) 1.30
National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J (2004) 1.27
Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J Pediatr (2008) 1.23
Height prediction from ulna length. Dev Med Child Neurol (2004) 1.20
A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research. Environ Health Perspect (2006) 1.20
Chloral hydrate sedation for infant pulmonary function testing. Pediatr Pulmonol (2014) 1.19
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J (2009) 1.17
Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus. Phytother Res (2005) 1.16
Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med (2005) 1.15
Parent-initiated oral corticosteroid therapy for acute asthma: a survey of current practice. J Paediatr Child Health (2007) 1.14
Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. J Paediatr Child Health (2006) 1.13
Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children: systematic review. J Paediatr Child Health (2007) 1.13
Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics (2002) 1.12
Surgical management of pulmonary artery sling in children. J Thorac Cardiovasc Surg (2012) 1.12
Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair. Biochemistry (2011) 1.10
Paracetamol use in early life and asthma: prospective birth cohort study. BMJ (2010) 1.09
Cough in children: definitions and clinical evaluation. Med J Aust (2006) 1.09
Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One (2011) 1.08
Benchmarks for cystic fibrosis carrier screening: a European consensus document. J Cyst Fibros (2010) 1.08
Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation. Genetica (2010) 1.06
Genetics in general practice. Aust Fam Physician (2014) 1.06
Comparison of subjective and objective measures in recurrently wheezy infants. Respiration (2002) 1.05
Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin Infect Dis (2011) 1.05
Discovery and development of exome-based, co-dominant single nucleotide polymorphism markers in hexaploid wheat (Triticum aestivum L.). Plant Biotechnol J (2012) 1.05
Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol (2013) 1.04
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. J Infect Dis (2004) 1.02
The use of non-bronchoscopic brushings to study the paediatric airway. Respir Res (2005) 1.02
Prediction of childhood pulmonary function using ulna length. Am J Respir Crit Care Med (2003) 1.01
Inhaled mannitol improves lung function in cystic fibrosis. Chest (2008) 1.00
Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses. J Allergy Clin Immunol (2002) 0.99
Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J Exp Med (2002) 0.99
Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA. PLoS One (2012) 0.99
A genome-wide search for linkage to asthma phenotypes in the genetics of asthma international network families: evidence for a major susceptibility locus on chromosome 2p. Eur J Hum Genet (2006) 0.98
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis (2004) 0.98
Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. BMJ (2003) 0.98
The limitations of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systematic review. Clin Biochem Rev (2007) 0.97
The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev (2005) 0.97
Clinical predictors and outcome of hypoxaemia among under-five diarrhoeal children with or without pneumonia in an urban hospital, Dhaka, Bangladesh. Trop Med Int Health (2011) 0.96
Staphylococcus aureus in early cystic fibrosis lung disease. Pediatr Pulmonol (2013) 0.96
A multicenter study on chronic cough in children : burden and etiologies based on a standardized management pathway. Chest (2012) 0.96
Hypoglycemia does not change the threshold for arousal from sleep in adolescents with type 1 diabetes. Diabetes Technol Ther (2011) 0.95
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis. Free Radic Biol Med (2010) 0.95
Clinical scoring systems in cystic fibrosis. Pediatr Pulmonol (2006) 0.95
Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clin Chem (2007) 0.94